196 related articles for article (PubMed ID: 3938090)
1. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.
Van Nieuwenhove S; Schechter PJ; Declercq J; Boné G; Burke J; Sjoerdsma A
Trans R Soc Trop Med Hyg; 1985; 79(5):692-8. PubMed ID: 3938090
[TBL] [Abstract][Full Text] [Related]
2. Further studies on difluoromethylornithine in African trypanosomes.
McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A
Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness.
Na-Bangchang K; Doua F; Konsil J; Hanpitakpong W; Kamanikom B; Kuzoe F
Eur J Clin Pharmacol; 2004 Jun; 60(4):269-78. PubMed ID: 15141331
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
Milord F; Pépin J; Loko L; Ethier L; Mpia B
Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
[TBL] [Abstract][Full Text] [Related]
5. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire.
Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K
Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients].
Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491
[TBL] [Abstract][Full Text] [Related]
7. African sleeping sickness in the United States. Successful treatment with eflornithine.
Petru AM; Azimi PH; Cummins SK; Sjoerdsma A
Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of lethal protozoal infections with the ornithine decarboxylase inhibitor, alpha-difluoromethylornithine.
Sjoerdsma A; Golden JA; Schechter PJ; Barlow JL; Santi DV
Trans Assoc Am Physicians; 1984; 97():70-9. PubMed ID: 6442954
[No Abstract] [Full Text] [Related]
9. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
De Groof D; Bruneel H; Musumari TS; Ruppol JF
Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
[TBL] [Abstract][Full Text] [Related]
10. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
Pepin J; Milord F; Guern C; Schechter PJ
Lancet; 1987 Dec; 2(8573):1431-3. PubMed ID: 2891995
[TBL] [Abstract][Full Text] [Related]
11. Polyamine metabolism: a potential therapeutic target in trypanosomes.
Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
Science; 1980 Oct; 210(4467):332-4. PubMed ID: 6775372
[TBL] [Abstract][Full Text] [Related]
12. Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness.
Milord F; Loko L; Ethier L; Mpia B; Pépin J
Trans R Soc Trop Med Hyg; 1993; 87(4):473-7. PubMed ID: 8249087
[TBL] [Abstract][Full Text] [Related]
13. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
[TBL] [Abstract][Full Text] [Related]
14. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
[TBL] [Abstract][Full Text] [Related]
17. Eflornithine. A new drug in the treatment of sleeping sickness.
Van Bogaert I; Haemers A
Pharm Weekbl Sci; 1989 Jun; 11(3):69-75. PubMed ID: 2505225
[TBL] [Abstract][Full Text] [Related]
18. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
19. Enantiospecific reassessment of the pharmacokinetics and pharmacodynamics of oral eflornithine against late-stage Trypanosoma brucei gambiense sleeping sickness.
Jansson-Löfmark R; Na-Bangchang K; Björkman S; Doua F; Ashton M
Antimicrob Agents Chemother; 2015 Feb; 59(2):1299-307. PubMed ID: 25512417
[TBL] [Abstract][Full Text] [Related]
20. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.
Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A
Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
